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We have used the four core genotypes (FCG) mouse model, which allows a distinction
between effects of gonadal secretions and chromosomal complement, to determine when
sex differences in the immune system first appear and what influences their development.
Using splenic T cell number as a measure that could be applied to neonates with as yet
immature immune responses, we found no differences among the four genotypes at
postnatal day 1, but by day 7, clear sex differences were observed. These sex differences
were unexpectedly independent of chromosomal complement and similar in degree to
gonadectomized FCG adults: both neonatal and gonadectomized adult females (XX and
XY) showed 2-fold the number of CD4+ and 7-fold the number of CD8+ T cells versus
their male (XX and XY) counterparts. Appearance of this long-lived sex difference between
days 1 and 7 suggested a role for the male-specific perinatal surge of testicular
testosterone. Interference with the testosterone surge significantly de-masculinized the
male CD4+, but not CD8+ splenic profile. Treatment of neonates demonstrated elevated
testosterone limited mature cell egress from the thymus, whereas estradiol reduced
splenic T cell seeding in females. Neonatal male splenic epithelium/stroma expressed
aromatase mRNA, suggesting capacity for splenic conversion of perinatal testosterone
into estradiol in males, which, similar to administration of estradiol in females, would result
in reduced splenic T cell seeding. These sex steroid effects affected both CD4+ and CD8+
cells and yet interference with the testosterone surge only significantly de-masculinized
the splenic content of CD4+ cells. For CD8+ cells, male cells in the thymus were also
found to express one third the density of sphingosine-1-phosphate thymic egress
receptors per cell compared to female, a male characteristic most likely an indirect
result of Sry expression. Interestingly, the data also support a previously unrecognized role
for non-gonadal estradiol in the promotion of intra-thymic cell proliferation in neonates of
both sexes. Microarray analysis suggested the thymic epithelium/stroma as the source ofn.org May 2021 | Volume 12 | Article 5826141
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Frontiers in Endocrinology | www.frontiersithis hormone. We conclude that some immune sex differences appear long before puberty
and more than one mechanism contributes to differential numbers and distribution of
T cells.Keywords: immune sexual dimorphism, T cell development, perinatal testosterone, intra-thymic estradiol, S1PR1,
Sry, thymic epithelium/stromaINTRODUCTION
Females have more robust immune responses after
immunization and infection when compared with males
[reviewed in (1)], but relatively little is known about the
genesis of this physiological sex difference. Because many
immune cells have receptors for gonadal steroids, analyses of
sex differences in immune responses have largely focused on the
reversible effects of gonadal steroids and their metabolites in
adult animals [e.g (2–5)]. These studies have produced abundant
evidence that gonadal steroids influence immune function.
However, sex differences in immunity seem to be more
complicated than simple regulation by postpubertal sex
steroids. For example, using the delayed-type hypersensitivity
response to Candida albicans, work from this laboratory has
shown female responses are more robust than those of males (6),
but ovariectomy increases rather than decreases the response (6).
Moreover, estradiol replacement dampens the response (6). This
is in agreement with studies from other laboratories, which
likewise show a dampening of multiple types of responses by
sex steroids in adults (7–14). Thus, although differential
dampening by sex steroids in males and females remains a
possible contributor to the greater female response, here we
considered additional possibilities such as long-lived effects of
prior exposure to gonadal hormones (organizational effects) and
differences in the sex chromosomal complement.
Chromosomal differences can arise either from the presence of
the Y chromosome in males or from gene dosage effects due to
incomplete inactivation of the X chromosome in females (15, 16).
To interrogate the potential contributory roles of organizational
hormonal effects and chromosomal complement, we used
gonadectomy and hormone manipulation in the “four core
genotypes” (FCG) mouse model.
In this work, we considered the possibilities that sex
differences might be present at birth as a result of chromosomal
complement or manifest shortly thereafter as a result of the
differential perinatal endocrine environment in the two sexes.
In regard to the latter, while one normally associates sex steroids
with puberty, there is an additional perinatal surge of testicular
testosterone that occurs in males, peaking around the day of birth
and falling within the adult range for concentration (17). There is
no equivalent production of testosterone or estradiol in females.
Because of the immaturity of perinatal immune responses, our
examination of sex differences was by necessity confined to numbers
of cells and influences on markers of proliferation and apoptosis.
Using these measures, we found no evidence of an effect of an XX
versus XY chromosomal complement. However, perinatal hormonal
manipulation uncovered heretofore unrecognized roles for sexn.org 2steroids in thymocyte proliferation, thymic egress and splenic T cell
seeding. In addition, we found evidence of a sex biasing effect specific
to developing male CD8+ cells that was neither dependent on
chromosomal complement nor the perinatal surge of testosterone.METHODS
Animals
FCG mice were obtained from the Jackson Laboratory (Bar
Harbor, ME) on a C57BL/6J background and bred and housed
under specific pathogen-free conditions, with controlled
temperature, humidity and 12h light/dark cycles. In the FCG
mouse model, the testis-determining gene, Sry, has been
“moved” from the Y chromosome to an autosome, allowing
the Y- chromosome and Sry to segregate independently. Mating
XY-(Sry+) gonadal males with XX gonadal females yields four
genotypes (18): XX females, XY- females that have equivalent
levels of estradiol as adults (19), and XXSry+males and XY-Sry+
males that have equivalent levels of testosterone both as adults
(20, 21) and perinatally (22). These genotypes are henceforth
abbreviated XXF, XYF, XXM and XYM, respectively. By
comparing genotypes with the same gonads but different
chromosomal complement, one can determine whether
gonadal hormones or gene expression from XX or XY sex
chromosomes causes a sex difference.
Anogenital distance was measured with calipers from the
middle of the anus to the base of the penis. Measurement
occurred without knowledge of the XXM versus XYM
genotype. For genotyping, DNA was extracted from tail clips
using the Qiagen (Valencia, CA) DNEasy kit per manufacturer
instructions. Classical PCR was performed using the genotyping
protocol recommended for FCG mice by Jackson laboratories
(21). We define “male” as a mouse with testes, and “female” as a
mouse with ovaries.
Gonadectomy of adults was performed at 10 weeks of age
under isoflurane anesthesia. Tissues were collected 4 weeks after
gonadectomy to reduce any effects of the surgery or lingering
effects of gonadal hormones on immune parameters. All drug/
hormone treatments used sesame oil/ethanol as control and
diluent and were delivered subcutaneously every day after
creating an emulsion by multiple passages through a 28-gauge
needle. Flutamide was used at 12.5mg/Kg in neonates and 35mg/
Kg in pregnant females (23), the latter delivered for 4 days before
parturition, letrozole at 20 mg/Kg (24), testosterone at 5mg/Kg
(23) and estradiol at 25mg/Kg (25) in neonates, all from Sigma-
Aldrich, St Louis, MO. Treatment with SiRNA was at 1, 3 and 5
days after birth. Sry SiRNA or Control SiRNA (Thermo FisherMay 2021 | Volume 12 | Article 582614
Ghosh et al. Perinatal Influences on ImmunityScientific, Carlsbad, CA) was diluted in sterile Dulbecco’s
phosphate buffered saline, complexed with invivofectamine 2.0
(Thermo Fisher Scientific) and dialyzed prior to administration,
as recommended by the company. The number of animals
contributing to a datum point is given in the figure legends.
Tissue/Cell Collection
At the various time points, mouse pups were sacrificed, blood
was collected into heparinized tubes, and the thymus and spleen
harvested and placed in RPMI 1640. For flow cytometry, each
blood sample was processed separately, but for assay of
testosterone, plasma from sets of 10-14 pups from several
litters was pooled, with replicates from different litters. To
obtain individual cells, lymphoid organs were pressed through
a 70 µM cell strainer using the soft plunger from a disposable 1
mL syringe. The number of cells obtained from neonatal
lymphoid organs was limited, thereby restricting the variables
that could be tested on cells from a single animal while making
sure there were enough event counts during flow cytometry.
Therefore, all experiments analyzing additional variables
included one previous stain to ensure comparability among
litters over time. Animal replicate numbers were also generally
high when endocrinologically manipulating neonates in order to
strengthen the data produced. When processed for epithelial/
stromal microarray analysis, thymocyte removal and remnant
tissue washing was repeated 5 times in the presence of RNase
OUT (Invitrogen, Carlsbad, CA). The tissue remaining after
removal of all thymocytes was snap frozen in liquid nitrogen and
stored at -80°C until RNA extraction for microarray analysis.
Microarray Analysis
RNA was extracted from the epithelium/stroma using a Qiagen
RNeasy mini for Microarray Analysis kit as per the manufacturer’s
instructions. An on-column DNAse digestion step was performed.
Target preparation/processing was performed by the DNA &
Protein MicroArray Facility, University of California, Irvine. All
RNA samples were quality assessed prior to beginning target
preparation/processing steps using an RNA 6000 Nano LabChip
and evaluation on an Agilent Bioanalyzer 2100 (Agilent
Technologies, Palo Alto, CA). Analysis used probe sets present
on an Affymetrix mouse GeneChip 1.0 ST array (Santa Clara, CA).
Arrays were scanned using the GeneChip Scanner 3000 7G and
GeneChip Operating Software v. 1.4 to produce.CEL intensity
files. Using the statistical environment R (R Core Team, 2014),
expression values were extracted from.CEL files and normalized
using RMA algorithm (R package “simpleaffy”). After the quantile
normalization, two-way ANOVA was performed to identify the
differentially expressed genes, with factors of gonadal sex (male vs.
female) and sex chromosome complement (XX vs. XY).
Benjamini-Hockberg (26) False Discovery Rate calculations were
applied. Data have been uploaded to GEO: GSE 135071.
RT-QPCR
RNA was quantified by nanodrop and equivalent amounts of
RNA were reverse transcribed using Oligo(dT)12–18 Primer
(18418-012 Invitrogen, Carlsbad, CA), M-MLV Reverse
Transcriptase (28025-013 Invitrogen), RNase OUT, and 10Frontiers in Endocrinology | www.frontiersin.org 3mM DNTP mix (invitrogen) for 1 hour at 37°C. Gene
expression was analyzed by Quantitative PCR using 2x SYBR
Green (Biorad, Hercules CA) and primers for GAPDH, Glcci,
Wisp3, aromatase (CYP19A1), sphingosine kinase (Sphk), and





(reverse)- GTCTTGTGGTGCACTGCCCT. CYP19A1 (forward)-
CTCAAGGGCGAGATGATAAGGT (reverse)- TCCTGT
CACTTGGAAGGGTG, Sphk (forward)- ATGTGGTGG
TGTTGTGTTTTGT (reverse)- CATGGTTCTTCCGTTCGGTG,
Sgpl1 (forward)- GCCTCTGCGGGGAAAGAAG (reverse)-
CAGGACACTCCACGCAATGA. Quantitative PCR was
performed with initialization at 95°C for 5 minutes, followed by
40 cycles of denaturation at 95°C 10 seconds and annealing 30
seconds. After each run, a melt curve was run to assess appropriately
amplified products.
Flow Cytometry
Reagents and antibodies were purchased from eBioscience (San
Diego, CA), BD Biosciences (San Jose, CA), R&D Systems
(Minneapolis MN), Abcam (Cambridge, MA), Alamone labs
(Jerusalem, Israel) or Santa Cruz Biotechnology (Santa Cruz,
CA). Antibodies included anti-CD4 (RM4-5), anti-CD8 (53-6.7),
anti-Ki-67 (SoIA 15), anti-CD90.1 (HIS 51), anti-CD44 (IM7),
anti-c-Kit (2B8), anti-CD25 (PC61.5), anti-Sca-1 (D7), anti-Bax
(B-9), anti-Qa2 (69H1-9-9), anti-S1PR1 (713412), anti-SPHK1
(ab95400), anti-S1PR3 (ASR-013-AG), mouse hematopoietic
lineage cocktail (17A2, RA3-6B2, M1/70, TER-119 and RB6-
8C5) and mouse IgG2a, IgG2b and rat IgG2b isotype controls, as
appropriate. Anti-androgen receptor (AR antibody N-20) and
anti-glucocorticoid receptor (GR antibody H-300) were rabbit
polyclonal IgGs and controls included use of a non-specific
rabbit polyclonal and second antibody alone. Fc receptors were
blocked using purified rat anti-mouse CD16/CD312 Ab (2.4G2)
(0.5 µg/100 µL). Intracellular staining was performed after cells
were stained for surface antigens, fixed and permeabilized (BD
Biosciences). Flow cytometry acquired intact cells, which were
further gated on the basis of forward versus side scatter to identify
lymphocytes and then analyzed after staining with conjugated
Abs. An example is provided as part of the Supplementary
Figures. This example shows forward versus side scatter,
followed by analysis of cells positive for CD4 and/or CD8 and
then, in this case, expression of sphingosine 1 phosphate
receptors 1 and/or 3. For AR and GR staining, fluorochrome-
conjugated mouse anti-rabbit IgGs were used as secondary
antibodies. For compensation controls, fluorochrome
conjugates along with non-stained controls were used to stain
BD Biosciences CompBeads to set the equipment. In each Ab
analysis, appropriate isotype controls were used to define
positivity and gate settings.
Statistical Analysis
Analysis of microarray data is described above. Excel statistical
software was otherwise used for two-way ANOVA [factors of sexMay 2021 | Volume 12 | Article 582614
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absent)] to assess group differences. Subsequently, pairwise
comparisons were made using Tukey’s test for multiple
comparisons or a simple Student t test for single comparisons.
A p-value < 0.05 was considered significant. Effect sizes were
computed by subtraction of the experimental mean from the
control mean divided by the control standard deviation. Because
our goal was to understand development of relative immune
competency, which is impacted by numbers and relative
numbers of cells, data are frequently presented as numbers of
cells within a compartment or this plus percentages. The
presentation of numbers of cells increases the errors because of
variability in cell recovery from the organs and errors due to
variation in animal size, particularly among neonates. However,
presentation of absolute numbers eliminates confounding aspects
of interpretation in percentage changes. i.e. a percentage may
increase because the numerator was increased or the denominator
was decreased. Litters were normalized to 5 ± 1 and runts were
eliminated from analyses. Flow cytometry was conducted before
genotyping and by a different individual to ensure blinded
analysis. The number of animals contributing to a datum point
in the various experimental groups is provided in the figure
legends. Although over the longer term, one would expect an even
distribution of genotypes, rarely was this observed in a given litter.
All data are derived from pups frommultiple litters, obtained and
analyzed on more than one occasion.RESULTS
Sex Differences in Gonadectomized
Adult FCG Mice
To establish measures of sex differences in the adult immune
system that could be applied to neonatal mice having immature
and inexperienced immune systems, we analyzed numbers of
CD4+ and CD8+ T cells in the spleen and thymus, and numbers
of CD19+ B cells and T regulatory cells (Treg) in the spleens of
gonadectomized adults. CD4+ T cells are helper cells that
stimulate other immune cells, including CD8+ T cells and B
lymphocytes. CD8+ T cells are cytotoxic cells responsible for
killing cells containing intracellular pathogens, such as viruses
and some bacteria, and cancer cells expressing abnormal
proteins. B cells will differentiate into antibody-producing cells,
and Treg cells (formerly known as T suppressor cells) moderate
immune responses, maintain self-tolerance and prevent
autoimmune diseases. Adult FCG mice were gonadectomized
at 10 weeks of age and analyzed 4 weeks later in order that any
effects of the surgery on immune cell numbers or lingering,
reversible effects of gonadal hormones would have dissipated.
Two-way ANOVA showed a significant main effect of sex, but no
effect of sex chromosome complement (XX vs. XY), and no
significant interaction between sex and sex chromosomal
complement. There were very different numbers of CD8+ and
CD4+ T cells in the spleens of females and males; the XYF and
XXF had 7-fold the number of CD8+cells and twice as many
CD4+ cells when compared to the XYM and XXM (FiguresFrontiers in Endocrinology | www.frontiersin.org 41A–D). Thus, even 4 weeks after removal of adult gonadal
hormones, a difference based on gonadal sex was evident in
the spleen. Using this measure, there was no difference based on
chromosomal complement since both male numbers (XXM and
XYM) and both female numbers (XXF and XYF) were the same.
Immune responses are dependent on both the overall number
of effector cells and the degree to which effector cells are
constrained by Tregs (27); no sex difference was observed for
Treg numbers in the spleen. However, a greater number of
potential effector T cells in females and the same number of
Tregs results in a lower percentage of Tregs in females (Figures
1E, F) which could theoretically manifest as more profound
immune responses, depending on their specificities. For B cells,
there was no overt effect of sex or sex chromosomal complement
(Figures 1G, H). Sex differences in T cell numbers or percentages
were not reflected in the thymus (Figures 2A–D) where there
was also no apparent effect of chromosomal complement or their
interaction on cell number.
Sex Differences in Neonatal FCG Mice
To determine when sex differences in splenic T cell number
became apparent, FCG neonates were examined at 1 and 7 days
postpartum. At day 1, there was no evidence of CD8+ or CD4+
sex differences in the spleens, whether plotted as all males versus
all females (not shown) or by genotype (Figures 3A–D).
However, by 7 days of age, full splenic sex differences were
evident, and, if anything, for CD4+ cells was greater than in the
adult (Figures 3E–H). Thus, sex differences became apparent
during the first week of life. This result does not preclude a
prenatal effect of sex-biasing factors that may have taken some
time to become evident. Nevertheless, it does establish the time
period during which the sex differences become physiologically
relevant to immunity. As was true for the adult, no sex difference
was evident for numbers of cells in the thymus or for Tregs or B
cells in the spleen at 7 days (Supplementary Figure 1).
In newborn mice, the spleen serves as an hematopoietic organ
since mice are born with a cartilaginous skeleton and essentially
no bone marrow cavity is initially available for this function (28).
Profound sex differences in T, but not B, cells suggested the effect
of gonadal sex was not on an early hematopoietic precursor
giving rise to both B and T cells. As anticipated, analysis of
splenocytes for the common T and B cell hematopoietic
progenitor (Lin-thy1loCD44+Sca+ckit+) showed no difference
in number between males and females when assessed for
individual genotypes (not shown) or when combining both
male and both female genotypes (Table 1A).
T cell sex differences in the spleen at 7 days could have arisen
by differential proliferation of T cells once in the spleen,
differential T cell egress from the spleen or differential seeding
from the thymus. Focusing first on proliferation and using Ki67
as a marker of proliferative capacity, no difference was observed
in the percentage of CD8+ or CD4+ cells that were Ki67 positive
between males and females when assessed in individual
genotypes (not shown) or when combining both male and
both female genotypes (Table 1A). i.e. there was no evidence
of preferential proliferation of cells in the female spleen. Adding
to general information about neonatal immunology, however, weMay 2021 | Volume 12 | Article 582614
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was Ki67+ at 7 days of age irrespective of sex (75% versus 48%,
respectively). This was an unexpected feature since neonates are
widely considered to have poor cytotoxic T cell responses (29).
During this first week of life, splenic white pulp is not yet
structured into T and B areas (compare Figure 4A with B), is
actively accumulating cells, and contributes few cells to the blood
(30). In the absence of sex differences in splenic T cell
proliferation and with little contribution to the blood, T cell
sex differences in the spleen seemed therefore most likely due to
differential seeding from the thymus.
Differential seeding from the thymus to the spleen via the
blood is supported by analysis of blood lymphocytes at 7 days,
which showed the same degree of sex difference as the spleen for
CD8+ cells (Figure 4C). The means for CD4+ cells also hinted at
a similar situation, but the differences were not statistically
significant (Figure 4D).Frontiers in Endocrinology | www.frontiersin.org 5There are a variety of markers associated with post-thymic
maturation, one of which is the expression of Qa2. As cells
mature in the periphery, the expression of surface Qa2 moves
from low to high (31). There were no main effects of sex or sex
chromosomal complement, nor an interaction of these two in the
percentage of cells expressing low levels of Qa2 between males
and females for either CD8+ or CD4+ cells (Table 1A). So, once
in the circulation, male and female cells mature at the same rate.
In the first week postpartum, the thymus is in high production
mode to supply the blood, connective tissues, and secondary
lymphoid organs. At 7 days, neither numbers of specific T cell
progenitors (CD4-CD8-thy1loCD25-CD44+ckit+) in the spleen
or thymus, nor percentages of Ki67+ or Bax+ thymocytes, were
different between males and females (Table 1A). Unexpectedly, a
large proportion of cells were positive for both Ki67 and Bax.
However, concurrence of parameters used as markers of both




FIGURE 1 | Cellular content (percentages and numbers) of adult FCG spleens 4 weeks after gonadectomy. Data are presented as a percentage of gated
lymphocytes present in the spleen except for Tregs (CD4+CD25+Foxp3+), which are presented as a percentage of CD4 single positive cells. Data are the mean ±
SD and are derived from 3-5 animals per genotype. **, different from both male genotypes, p<0.01.May 2021 | Volume 12 | Article 582614
Ghosh et al. Perinatal Influences on Immunitythymocytes in a study using DNA content as a measure of
apoptosis and both Ki67 and proliferating cell nuclear antigen
as proliferation markers (32).
The results also show no significant difference in percentage
of Ki67+ or Bax+ cells between males and females when
analyzing different thymocyte developmental stages in control,
sesame oil-treated animals either by individual genotype (not
shown) or by gonadal sex (Table 1B and Figures 5A, C, E, G, I
sesame oil control values). Cells progress from being CD4CD8
double negative through CD4CD8 double positive to either CD4
or CD8 single positive before release from the thymus. There was
also no difference in numbers of cells between males and females
at different developmental T cell stages (Figures 5B, D, F, H, J
sesame oil control values). With no difference in numbers, the
rates of proliferation, as indicated by Ki67, and apoptosis, as
indicated by Bax positivity, appear to be the same for both sexes.
However, if there were different rates of exit from the thymus,
this conclusion would not be accurate, as discussed later. Because
relative expression of Bax per cell might have produced
differential susceptibility to apoptosis, this was also analyzed
for each T cell developmental stage. Again, relative expression
per cell was the same in males and females (Supplementary
Figure 2 sesame oil control values).
Hormonal Effects on the FCG
Neonatal Spleen
In males, there is peripartum, testicular Leydig cell production of
testosterone, peaking around the day of birth, and falling within
the adult range for concentration (17). There is no equivalent
production of testosterone or estradiol in females. Limited
sampling confirmed a testosterone surge in male FCG mice
and equivalent levels in both adult male genotypes
(Supplementary Table 1). In addition, previous work by ItohFrontiers in Endocrinology | www.frontiersin.org 6et al. (22) demonstrated no difference in the anogenital distance
of FCGmice, suggesting that perinatal exposure to testosterone is
approximately equivalent between the XXM and XYM
genotypes. In the present study, we have confirmed the result
of Itoh et al. (22) that XX and XY FCG males have
indistinguishable rates of increase in anogenital distance
(Figure 6). These data confirm the likelihood that both FCG
male genotypes are exposed to similar perinatal levels
of testosterone.
To test the potential role of perinatal testosterone in the
development of the splenic male-female sex differences, we
employed the competitive antagonist, flutamide (33), with the
expectation that flutamide would block male-typical
development of the splenic profile and increase the number of
T cells. Because perinatal testosterone is often aromatized to
estradiol to accomplish its masculinizing effects (21), we also
tested if the aromatase inhibitor, letrozole, blocked
masculinization (34). Because of the potential to alter the
dam’s endocrinology and thereby complicate analyses specific
to events occurring in the pups, the drugs were given to the pups
between days 1 and 7 postpartum. Since a proportion of the
peripartum surge would already have taken place, we expected
that the drugs might cause significant, but incomplete blockade
of masculinization. Both flutamide and letrozole had a
significantly de-masculinizing effect and approximately
doubled the number of CD4+ T cells in the FCG male spleens,
with no effect on the number of CD4+ cells in the FCG female
spleens (Figures 7A, B). Thus, perinatal testosterone was
responsible for at least a large part of the decreased numbers
of CD4+ cells in the male spleen. However, there was no evidence
that the same was true for CD8+ cells, even though the sex
differences were greater for CD8+ cells; neither flutamide nor
letrozole significantly increased CD8+ cells in the male spleenA B
C D
FIGURE 2 | Cellular content (percentages and numbers) of adult FCG thymi 4 weeks after gonadectomy. Data are presented as a percentage of gated thymocytes
(mean ± SD) and are derived from 3-5 animals per genotype.May 2021 | Volume 12 | Article 582614
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female spleen also indicated specificity of the effect.
Effects of Flutamide and Letrozole in the
FCG Neonate Thymus
Flutamide and letrozole caused a small, but significant, reduction
in Ki67 positivity of CD4CD8 double positive and CD4 single
positive cells in the female thymus (Table 1B) and both drugs
resulted in a major reduction in the percentage of Bax+
thymocytes at all developmental stages in both sexes (Figures
5A, C, E, G, I). This result implied that a degree of proliferation
of some subsets and substantial promotion of Bax expression/
apoptosis of all thymocytes is brought about by testosterone
aromatized to estradiol. Furthermore and importantly, since
there is no peripartum surge of testosterone in females, the
source of the steroids being affected by flutamide and letrozole
was not testicular, at least in females. However, even with theFrontiers in Endocrinology | www.frontiersin.org 7imbalance between the degree of effect on Ki67 and Bax
positivity, there was no net effect on thymic cell number
(Figures 5B, D, F, H, J).
To determine whether the thymic epithelium could be the
source of the testosterone and estradiol affected by
administration of flutamide and letrozole, microarray analysis
of gene expression in day 7 thymic epithelium/stroma was
performed. Thymic epithelium/stroma showed expression of
all necessary enzymes required to produce testosterone and its
aromatization to estradiol, and no difference in expression
between FCG gonadal males and females (Supplementary
Table 2) or any of the genotypes (individual genotype data not
shown). Although mRNA expression cannot assess relative
activity of these enzymes, these data are at least consistent with
the observed equivalent effects of flutamide and letrozole within
the thymus of both males and females and the necessity for




FIGURE 3 | Mature T cell content (percentages and numbers) of the spleens of pups at 1 and 7 days of age. Data are presented as a percentage of gated
lymphocytes. The means ± SD are derived from 17 XYM, 14 XXM, 15XXF, and 16 XYF animals at day 1, and 13 XYM, 14 XXM, 22 XXF, and 13 XYF animals at day
7. **, different from both male genotypes, p < 0.01.May 2021 | Volume 12 | Article 582614
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C D
FIGURE 4 | Pup spleen histology at 7 and 28 days and T cell content of the blood at 7 days. Spleens were fixed and embedded in JB4 (a water soluble, glycol
methacrylate-based embedding medium) before sectioning (@ 2.5 mm) and staining with hematoxylin and eosin. Magnification, 40X and 100X for insets. Blood was
collected into heparinized tubes and the red blood cells lysed prior to staining for flow cytometry. Data in c and d are presented as a percentage of gated
lymphocytes. The means ± SD are derived from 13 XYM, 14 XXM, 22 XXF, and 13 XYF animals at day 7. ***, different from both male genotypes, p<0.001.TABLE 1 | Cell values 7 days postpartum comparing both male to both female genotypes.
A: No treatment
Spleen Spleen Spleen Blood Blood Spleen











Number thymic progenitors CD4-CD8-
thy1loCD25-CD44+ckit+ (x 10-5)
Male 14.7 ± 6.8 46.6 ± 7.1 75.9 ± 5.2 57.2 ± 18.6 42.4 ± 20.7 1.86 ± 0.8
Female 18.0 ± 13.5 52 ± 7.4 75.5 ± 6.3 68.7 ± 16.5 43.9 ± 20.3 1.42 ± 0.9
Thymus Thymus Thymus No male-female differences were significant






Male 3.3 ± 1.9 92.4 ± 3.4 51 ± 29.7
Female 3.7 ± 2.4 91.8 ± 1.3 68.2 ± 37.8Frontiers in Endocrinology | www.frontiersin.org 8B. After treatment with flutamide or letrozole between days 1 and 7.
Percent double negative thymocytes
also Ki67+






Male 64.5 ± 5.7 92.7 ± 4.3 92.4 ± 3.0 97.0 ± 1.8
Male + Flu 67.4 ± 1.8 85.1 ± 2.8 83.9 ± 6.1 94.3 ± 2.7
Male + Let 65.6 ± 8.9 84.6 ± 5.2 84.7 ± 5.5 91.4 ± 6.2
Female 69.4 ± 4.7 91.5 ± 1.8 93.3 ± 3.8 96.6 ± 3.5
Female +
Flu
68.0 ± 3.6 83.1 ± 3.0 * 80.4 ± 6.6 * 92.9 ± 2.3
Female +
Let
61 ± 17.4 78.7 ± 17.5 * 80.6 ± 11.0 * 89.1 ± 10.6
All values mean ± SD. *, different from control, p<0.05.May 2021 | Volume 12 | Article 582614
Ghosh et al. Perinatal Influences on ImmunityIn keeping with the flutamide and letrozole results on Bax
expression, others have described a major effect of testicular
testosterone to promote T cell apoptosis in the thymus, mediated
through testosterone stimulation of local corticosteroid
production (35). As shown in Supplementary Table 2,
androgen receptors (AR) are expressed in the neonatal thymic
epithelium/stroma, as is CYP11A1, the enzyme responsible for
production of pregnenolone and rate limiting for corticosterone
synthesis (36), as well as CYP11B1 that converts 11-
deoxycorticosterone into corticosterone. However, there was
no difference in levels of expression between males and
females. Thymocyte apoptosis in response to corticosteroneFrontiers in Endocrinology | www.frontiersin.org 9would require expression of glucocorticoid receptors (GR).
Flow cytometric determination of the percentage of cells
expressing, or the expression level per cell, at days 1 and 7 of
these or androgen receptors (AR) showed no difference between
males and females at any thymocyte developmental stage
(Supplementary Figures 3 and 4). These data are again
consistent with equivalent effects of flutamide and letrozole on
Bax expression in males and females.
Results to this point, while suggesting a potentially important
role for intra-thymic local testosterone/estradiol in the regulation
of thymocyte number, have not explained sex differences in





FIGURE 5 | Effect of flutamide and letrozole on the percentage of cells expressing Bax and the number of cells in the thymus of pups. FCG Mouse pups were
treated between days 1 and 7 postpartum before collection of thymi. Data are presented as a proportion of gated lymphocytes. The means ± SD are derived from 6
males and 8 females in the sesame oil control group, 7 males and 13 females in the flutamide group and 11 males and 7 females in the letrozole group. Males
include both XYM and XXM (solid bars) and females include both XXF and XYF (cross-hatched bars). S, sesame oil control; F, flutamide; L, letrozole. Different from
same sex control *p < 0.05; **p < 0.01; ***p < 0.001.May 2021 | Volume 12 | Article 582614
Ghosh et al. Perinatal Influences on Immunityflutamide and letrozole on the numbers of CD4+ cells in the
spleen. There must therefore be an additional mechanism of
action of these drugs in males.
Effects of Hormone Treatment on the FCG
Neonate Thymus
To consolidate developing hypotheses and determine what
additional effect testosterone had in males, FCG pups of both
sexes were treated with testosterone or estradiol between days 1
and 7. Contrary to what one might expect given that the greater
effect of flutamide and letrozole was to decrease Bax expression,
both testosterone and estradiol increased total thymocyte, double
positive and double negative cell number by about 60% (Figures
8A, B, E). For single positive cells, only testosterone increased
cell number (both CD8+ and CD4+). (Figures 8C, D). In other
words, there was also a testosterone-specific effect on cells
mature enough to leave the thymus.
In the thymus, the effects of treatment with testosterone and
estradiol were very similar in males and females. However, under
normal circumstances, only the male would experience a surge of
testicular testosterone that would result in an increase in the
number of single positive cells in the thymus. An increase in the
number of single positive cells could be the result of increased
production/maturation, or more likely given both the reduced
number in the spleen and the difference from estradiol, from
inhibition of final maturation/release. However, if the only
difference between males and females contributing to sexual
dimorphism in the spleen were inhibition of release of single
positive cells from the thymus by testosterone in males, then we
should have seen a reduction in single positive cells in the spleen
of both males and females with testosterone treatment and weFrontiers in Endocrinology | www.frontiersin.org 10did not (Figures 9A, B). Although the trend was towards a
reduction with additional testosterone administration in males,
this was not duplicated in females. Furthermore, the trend in the
male spleen was replicated by estradiol, which did not inhibit
release from the thymus. In other words, there is another sex-
specific effect at the level of the spleen independent of effects on
the thymus that suggested the ability of the male, but not female
spleen to aromatize testosterone. To determine whether there
might be a differential ability of splenic stroma to aromatize
testosterone to estradiol, expression of aromatase mRNA in
splenic epithelium/stroma was examined by qPCR. Figure 10
shows that epithelium/stroma from FCG males (XY and XX)
expresses CYP19A1 at about two to three times the level of FCG
females (XY and XX). Thus, making the assumption of relative
enzyme activity on the basis of relative mRNA expression,
spleens from FCG gonadal males do have increased potential
for aromatization of testosterone to estradiol.
CD8+ Cells
Splenic sexual dimorphism is greatest for CD8+ cells. We
therefore anticipated being able to see larger responses to
experimental manipulation for these cells versus CD4+ cells,
but that was not the case. Other than testicular testosterone, the
only entity common to both male genotypes and not present in
either female genotype was the Sry gene. We therefore used aFIGURE 6 | Anogenital distance development in FCG male pups. Anogenital
distance was measured daily until weaning. Data are presented as the mean
± SD. No significant difference was found between XYM and XXM genotypes
on any day analyzed by repeated measure 2-way ANOVA with post-hoc
Sidak corrections for multiple comparisons. n = 4 XXM and 5 XYM pups.A
B
FIGURE 7 | Effect of flutamide and letrozole on numbers of cells in the pup
spleen. FCG Mouse pups were treated between days 1 and 7 postpartum
before collection of spleens. Data are derived from gated lymphocytes,
presented as the mean ± SD, and are derived from the same animals as for
Figure 5. S, sesame oil control; F, flutamide; L, letrozole. Males include both
XYM and XXM (solid bars) and females include both XXF and XYF (cross-
hatched bars). Different from same sex control *, p< 0.05, effect size 1.25.May 2021 | Volume 12 | Article 582614
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FIGURE 9 | Effect of testosterone and estradiol on cell numbers in the spleen. FCG Mouse pups were treated between days 1 and 7 postpartum before collection
of tissues. Data are derived from gated lymphocytes, presented as the mean ± SD, and are derived from 6 males and 5 females in the control group, 3 males and 3
females in the testosterone group and 5 males and 7 females in the estradiol group. S, sesame oil control; T, testosterone; E, estradiol. Males include both XYM and




FIGURE 8 | Effect of testosterone and estradiol on cell numbers in the thymus. FCG Mouse pups were treated between days 1 and 7 postpartum before collection
of tissues. Data are derived from gated lymphocytes, presented as the mean ± SD, and are derived from 6 males and 5 females in the control group, 3 males and 3
females in the testosterone group and 5 males and 7 females in the estradiol group. S, sesame oil control; T, testosterone; E, estradiol. Males include both XYM and
XXM (solid bars) and females include both XXF and XYF (cross-hatched bars). Brackets show difference between included bars, with the asterisk designating the
degree of significance for these and those compared to same sex control *p < 0.05; **p < 0.01; ***p < 0.001.
Ghosh et al. Perinatal Influences on Immunitycommercially-available SiRNA to knock down Sry expression
postnatally. The ability of this SiRNA to knock down Sry
expression in the testes is shown in Figure 11A. Knockdown
of about 40% compared to control SiRNA was achieved. If we
had confined our analysis to males, the results would have
supported a very important role for Sry expression in the
development of immune sex differences since knockdown
doubled the number of splenic CD4+ and CD8+ cells in males,
largely feminizing the CD4+ profile and partially feminizing the
CD8+ profile in the spleen (Figures 11B, C). Unfortunately,
however, the same effect was observed in females (Figures 11B,
C), indicating that the action of the SiRNA was not specific to
Sry. Nevertheless, we felt it important to include the results here
because a) it is an obvious experiment to perform and its absence
would have been notable and b) it was important to draw
attention to the lack of specificity of an SiRNA marketed as
specific. Unfortunately, there is no viable, alternative SiRNA.
After in silico analysis of potential non-specific effects of the
SiRNA, we examined the effect of the “Sry” SiRNA on expression
of Chordin-like 1 and found it was increased (Figure 11D).
Chordin-like 1 is an antagonist of bone morphogenic protein-4,
which in turn inhibits the progression of double negative to
double positive thymocytes (37). Therefore, an increase in the
antagonist of an inhibitor of T cell maturation would be expected
to increase thymic output of T cells. This seems a likely
explanation for the non-specific effect of the SiRNA.
Supporting this explanation, Figure 11E shows an increase in
double positive cells in the thymi of both FCG males and females
after treatment with the “Sry” SiRNA.Frontiers in Endocrinology | www.frontiersin.org 12Examination of the numbers of CD8+ cells in the spleens
shows about equal numbers of CD8+ cells in FCG males and
females at day 1 (Figure 3B), an ~ 10 fold increase from day 1 to
day 7 in male genotypes, and an ~ 100 fold increase in female
genotypes (Figure 3F), suggesting that the effect of gonadal sex
on CD8+ cell production may already have been in place on day
1. To be sure that this was not an early effect of the perinatal
testicular testosterone surge, pregnant dams were treated with
flutamide for 4 days before parturition and splenic CD8+ cell
numbers were examined on postnatal day 1. Flutamide had no
effect (data not shown).
Given the early effect of gonadal sex on splenic cell numbers
and the maintenance of the sex difference throughout life
(compare Figures 1 and 3) we considered the possibility that
sex had a permanent effect on gene expression in the thymic
epithelium/stroma. However, the gonadal sex differences in gene
expression were small. Of the 73 genes that displayed statistically
significant sex differences in expression, there were only two that
exhibited both a fold difference of 0.2 or greater and a probe level
expression of 200 or higher (GEO: GSE 135071). These were
Glucocorticoid induced transcript 1 (Glcci1) andWnt1 Inducible
signaling pathway protein 3 (Wisp3), and both were expressed
higher in females. In a new set of 8 males and 8 females,
quantitative RT-PCR did not confirm the difference for Glcci1,
but did confirm a sex difference inWisp3, which was expressed at
a 70% higher level in female thymic epithelium/stroma
(Figure 12A).
Because of the crucial role of sphingosine-1-phosphate (S1P)
in thymocyte egress, we also examined expression of proteins
that contribute to the S1P chemotactic gradient (38). The
amount of S1P is affected by the kinase that produces it and
the lyase that breaks it down. Sphingosine-1-phosphate lyase 1
(Sgpl1) is produced by thymic epithelium and dendritic cells (38)
and decreases the amount of S1P around the maturing
thymocytes relative to the blood (39). The S1P in the blood
then has a chemotactic effect on single positive thymocytes ready
to leave. Initially, we hypothesized that thymi of gonadal females
would express higher levels of the lyase, thereby making egress of
thymocytes easier. However, there was no significant difference
between FCG gonadal males and females in expression of mRNA
for either the kinase or lyase (data not shown).
In order to respond to gradients of S1P, thymocytes express
S1P receptors. Although the S1P receptors are a family of five G
protein-coupled receptors (40), S1PR1 has been reported to be
the most important in the thymus (41). However, S1PR3 has a
potential Sry response element and so we considered the
possibility that it could also have been of significance to the
sex difference. Flow cytometry (see Supplementary Figure 5 for
gating strategy and dot plots) showed that for CD4+ cells, a
larger proportion of female versus male cells expressed S1PR1
and/or S1PR3 (Figure 12B). For CD8+ cells, the mean
fluorescence intensity (MFI) for both cell surface receptors was
much higher than for CD4+ cells (Figure 12C), suggesting
greater reliance on the S1P gradient for thymic egress of CD8+
cells. In addition, there was a substantial sex difference in the
MFI for S1PR1 on CD8+ cells, with female cells expressing ~4-
fold the density of male cells (Figure 12C).FIGURE 10 | Aromatase expression at postnatal day 7 in splenic epithelium/
stroma from FCG gonadal males versus gonadal females. Expression is
normalized to GAPDH. Data are presented as a box and whisker plot and X
denotes the mean. N = 13 male (both XYM and XXM) pups (solid bars); n =
11 female (both XXF and XYF) pups (cross-hatched bars). Males different
from females, *p < 0.05, effect size 1.12.May 2021 | Volume 12 | Article 582614
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The Experimental Model
We have used the FCG mouse model to determine when
measurable sex differences in the immune system first appear
and what influences their development. Because our pilot data
indicated early appearance of T cell sex differences at a time
when T-cell immune responses are immature, we examined sex
differences by focusing on relative T cell numbers. We chose the
FCG model because we expected to discover effects due to both
chromosomal complement and neonatal endocrinology.
However, using the measures reported, we saw no
chromosomal complement effects and hence have displayedFrontiers in Endocrinology | www.frontiersin.org 13many results as just gonadal male versus female to make the
many graphs and tables somewhat easier to digest. Our findings
using these measures in no way eliminate the possibility that a
two X versus an X and Y chromosomal complement plays
additional roles in sex differences in specific immune
responses. Indeed, a chromosomal effect has been reported in
the FCG model when examining susceptibility to experimental
autoimmune encephalitis, a model for multiple sclerosis (42, 43).
Basis of the Observed Sex Difference
Our finding that the splenic cell number sex difference was
evident in adult animals gonadectomized 4 weeks earlier shows
that what we are measuring is not the result of activational,A
B C
D E
FIGURE 11 | Use of the SiRNA for Sry had similar effects in male and female FCG pups. Knockdown of Sry within the male testes was confirmed (A), but both male
and female animals showed an increase in both CD4+ and CD8+ cells in the spleen as a consequence of treatment (B, C). Use of the Sry SiRNA raised expression
of chordin-like 1 (D) and increased the number of double positive cells in the thymus of treated animals (E). Mouse pups were treated with the Sry or control SiRNA
between days 1 and 7 postpartum before collection of tissues. Data are presented as the mean ± SD and are derived from 3 males and 11 females for control
SiRNA treatment groups and 9 males and 5 females for Sry SiRNA treatment groups. Males (solid bars in B, C); Females (cross-hatched bars in B, C). Different from
control SiRNA *p < 0.05; **p < 0.01.May 2021 | Volume 12 | Article 582614
Ghosh et al. Perinatal Influences on Immunityreversible effects of gonadal hormones i.e. that the cell number
difference is unlike the effects of gonadal hormones for example
on expression of the autoimmune regulator, AIRE (44, 45),.
Nevertheless, and as mentioned in the introduction, modulatory
and reversible effects of sex steroids on immune responses do
occur [e.g (2–5).]. While considering AIRE, it is worth
mentioning that there was no gonadal sex-based differential
expression in the day 7 neonatal thymi (see microarray data
uploaded to GEO: GSE 135071), consistent with the findings of
others (44).
Because the sex difference appears by postnatal day 7 and was
not influenced by the number and type of sex chromosomes, we
were left with two important differences between males and
females: the perinatal testosterone surge and expression of Sry,
which is the only gene by necessity left associated with gonadal
maleness in the FCG model.Frontiers in Endocrinology | www.frontiersin.org 14Sex Steroids and Thymocyte Development
Concurrent analysis of both sexes proved invaluable to dissection
of the effects of the perinatal surge in testosterone and eventual
production of the model shown in Figure 13. Without analysis in
both sexes, we would not have been able to unravel the
differential effects of the sex steroids in the thymus and spleen
and we would have been completely misled by the SiRNA
knockdown of Sry.
Since there is no peripartum surge in gonadal testosterone in
females and yet the testosterone antagonist, flutamide, and the
aromatase inhibitor, letrozole, had equivalent effects on both
Ki67 and Bax expression in male and female thymocytes, we
conclude that there is some other source of these hormones
available to influence thymocyte development, regardless of sex.
At least based on microarray analysis of gene expression, this
alternate source could be the thymic epithelium/stroma. TheA B
C
FIGURE 12 | Sexually dimorphic expression of thymic Wisp3 mRNA and Expression of type 1 and 3 receptors for sphingosine-1-phosphate on CD4+ and CD8+
cells from postnatal day 7 FCG pup thymi. RNA from thymic epithelium/stroma of male and female FCG mice at post-natal day 7 was analyzed for Wisp3 mRNA
expression by RT-QPCR (A). Data are presented as relative mRNA expression normalized to GAPDH and setting the male value as 1. n = 8 males (both XXM and
XYM, solid bar) and 8 females (both XXF and XYF, cross-hatched bar). *p < 0.05. Percentage of cells expressing either S1PR1 or S1PR3 (B) and mean fluorescence
intensity for these receptors (C). Data are shown as box and whisker plots. X= mean. n = 11 females and 13 males. Males includes both XYM and XXM (solid bars)
and females includes both XXF and XYF (cross-hatched bars). *p <0.05. Effect size for CD8+PR1 MFI in males versus females (C) is 1.48.May 2021 | Volume 12 | Article 582614
Ghosh et al. Perinatal Influences on Immunityapproximate equivalence of flutamide and letrozole and
testosterone and estradiol on intrathymic parameters also
shows that testosterone needs to be aromatized to estradiol to
exert this effect. The microarray analysis further showed that the
thymic epithelium/stroma expresses all necessary enzymes for
the aromatization of locally produced testosterone in both sexes.
While we cannot exclude an alternate non-gonadal source of the
hormones and indirect effects, there are no measurable amounts
in the circulation of female neonates (22). Therefore, production
within the thymus where hormone effects can be integrated with
other micro-environmental cues seems most likely. Also,
although expression of the enzymes does not necessarily
translate to activity, others have at least demonstrated activity
of the first part of the biosynthetic pathway by measuring
pregnenolone accumulation after inhibition of later steps in
steroidogenesis (46, 47). With demonstrated expression of the
rest of the necessary enzymes, continuation to the production of
estradiol seems likely.
The effects of flutamide and letrozole on Bax and Ki67 were
initially a great puzzle since in most tissues, one would normally
expect opposite effects of treatments on the expression of Bax
and Ki67. However, in thymocytes, both drugs decreased the
percentage of cells expressing Bax, which might be expected to
increase cell number, as well as decreasing the percentage
expressing Ki67, which might be expected to decrease cellFrontiers in Endocrinology | www.frontiersin.org 15number. Given that the Ki67 results are supported by the
administration of testosterone (and estradiol) which increased
cell number, we assume that Ki67 more accurately reflects what
is happening and that Bax expression is not necessarily indicative
of a cell undergoing apoptosis. In this regard, it is interesting that
we observed concurrence of Bax and Ki67 expression, a
phenomenon that has been previously described by others (32)
thereby suggesting that Bax expression per se is not directly
indicative of apoptosis. In addition, an approximately 60%
reduction in Bax+ cells had no effect on cell number. Bax had
seemed like a good choice of apoptotic marker given the
literature on its important role in apoptosis of double positive
thymocytes (48), but clearly the regulation of apoptosis,
especially during negative selection, is more complex (49).
Administration of testosterone or estradiol increased the
number of cells in the thymus. While the effect of testosterone
to increase thymocyte number could have been secondary to
inhibition of release of mature single positive cells, this could not
be the explanation for the increase in thymocytes with estradiol
since there was in this case no significant effect on the number of
single positive cells in the thymus. We deduce from the reduced
number of Ki67+ cells with aromatase inhibitor that endogenous
thymic estradiol has a positive influence on the proliferation of
thymocytes in the neonate, more specifically on the number of
double positive and single positive CD4 cells (Table 1B). This is aFIGURE 13 | Working diagram illustrating the results. Estradiol (E) produced by the thymic epithelium/stroma stimulates proliferation of double positive (DP) and CD4
single positive cells. While administered testosterone (presumably aromatized to estradiol) and estradiol also had a stimulatory effect on double negative (DN) and
CD8 single positive cell number, we are basing the preference for stimulation of the pathway leading to the production of CD4+ cells on the flutamide and letrozole
results on the assumption that these results are more likely representative of the effect of physiological levels of locally produced steroids. In males, there is a
peripartum surge of testosterone produced by the Leydig cells in the testes. This testosterone inhibits release of mature cells from the thymus. This activity is
testosterone-specific (i.e. it is not aromatized). In the spleen, some of this testosterone is aromatized to estradiol, which in turn inhibits T cell seeding of the spleen.May 2021 | Volume 12 | Article 582614
Ghosh et al. Perinatal Influences on Immunityheretofore unrecognized role for estradiol in pre-pubertal thymic
physiology (illustrated in Figure 13). Given the rejuvenating
effects of gonadal sex steroid ablation on older thymi [reviewed
in (50)], this was an unexpected finding. However, there is ample
precedent for opposite effects of gonadal steroids in neonates
versus mature animals [e.g (51)].
Sex Steroids and Thymic Egress
The finding of an unexpected, non-gonadal source of sex steroid
that impacts thymocyte development complicated interpretation
of results with administration of both flutamide and letrozole,
but administration of testosterone and estradiol to both sexes
helped to sort through the possible interpretations. Once
thymocytes are mature single positive cells, they would
normally exit the thymus. Since the thymic content of single
positive cells increased in response to testosterone, but not
estradiol, in both sexes, the results support a role for
testosterone in inhibiting either the final maturation of single
positive cells in the thymic medulla (52) or the movement of cells
through the emigration barriers of thymic epithelium and vessel
endothelium and associated basal laminae (53).
Sex Steroids and Splenic Seeding
Although administration of testosterone to males and females
showed the same effect in the thymus and testosterone reduced
splenic seeding in males, there was not an equivalent reduction in
splenic T cells in response to testosterone in females. Therefore,
we considered the additional existence of a sex difference in post-
thymic distribution of T cells, especially as we could find no
evidence of differential proliferation of T cells once in the spleen
between the sexes. Estradiol decreased splenic content of T cells
in females, a result consistent with the effects of neonatal
letrozole to increase CD4+ T cells in the male spleen. In other
words, following the perinatal surge of testosterone comes
inhibition of release of T cells from the thymus and reduced
seeding to the spleen, with the former dependent on testosterone
itself and the latter requiring aromatization of testosterone to
estradiol (illustrated in Figure 13). Making the assumption that
mRNA for the aromatase is reflective of relative enzyme activity,
the gonadal male spleen has a superior ability to aromatize
testosterone and therefore to block T cell seeding to the spleen.
Furthermore, the neonatal male spleen is the only one exposed to
a source of circulating testosterone to serve as substrate
for aromatization.
Organizational Effects
The degree of sex difference in splenic cell number is the same at
7 days of age as in gonadectomized adults. This implies that the
consequences of the perinatal surge in testosterone and Sry
expression on thymic release and splenic seeding are
irreversible and organizational in nature and likely related to
epigenetic changes. For thymic epithelium/stroma, there were
surprisingly few differentially expressed genes, although females
expressed Wisp3 at a 70% higher level. Since thymic function has
not been examined in Wisp3 transgenic or knockout mouse
models, we can only speculate at this time about what this mightFrontiers in Endocrinology | www.frontiersin.org 16mean. However, Wisp3 is a member of the CCN (CTGF, CYR61,
and NOV) family of connective tissue growth factors. Secreted
CCNs regulate cell proliferation, survival, migration, adhesion,
differentiation, and extracellular matrix formation (54–58), and
hence Wisp3 could have multiple influences during T cell
maturation in the thymus. For example, Wisp3 binds to and
inhibits bone morphogenic protein (BMP) (57, 58) and, as
mentioned earlier, BMP4 inhibits thymocyte proliferation and
progression from the double negative to the double positive stage
(37). Inhibition of an inhibitor of thymocyte maturation would
permit eventual increased output of single positive T-cells in
females. Additionally, Wisp3 may affect extracellular matrix (54–
56) and therefore both migration within, and emigration from,
the thymus. Interestingly, the Wisp3 promoter has a potential
Sry/Sox response element at -383, which could participate in
repression of Wisp3 expression in gonadal males. For splenic
seeding inhibited by estradiol, long-lasting effects may include
aromatase expression at about double-triple in males versus
females. Finally, we have the sex difference in thymocyte
expression of the S1PRs. Given that CD4+ and CD8+ cells
derive from CD4CD8 double positive cells, sex specific
expression of S1PRs must be influenced during differentiation to
the single positive stage. Comparing gonadal females and gonadal
males, a greater percentage of CD4+ cells expressed S1PRs in
females and the number of S1PR1 receptors per CD8+ cell was
greater. Both of these findings would be expected to enhance T cell
thymic egress in females and hence produce a greater potential for
splenic seeding. Conversely, a reduced percentage of cells
expressing S1PRs and CD8+ cells with a lower expression of
S1PR1 in males would be expected to reduce thymic egress and
therefore the potential for splenic seeding. In addition, reduced
expression of these receptors in males may dictate the destination
of many of those released from the thymus; low expression of
S1PR1 is characteristic of localization to non-lymphoid tissues
(59). It is possible therefore that in addition to what we have
uncovered in regard to splenic seeding, sex differences in the
seeding of peripheral tissues may contribute to the numbers of
CD8+ cells present or not present in the spleen.
Origin of the S1PR1 Sex Difference
The working model provided as Figure 13 shows what we have
been able to deduce about hormonal effects on the thymus and
spleen for both CD4+ and CD8+ T cells but does not account for
the much greater sex difference seen for CD8+ cells. Given a) the
demonstration that the CD8+ difference is not brought about by
the perinatal surge of testosterone in males, b) the fact that the
only other difference between both male and both female
genotypes is the expression of Sry, and c) with the exception of
Wisp3, the minor differences in thymic epithelial expression
between the sexes, it seems most likely that the sex difference is
an effect of Sry on S1PR1 expression within the CD8+ cell itself
once committed to this differentiation. However, in the absence
of a known Sry response element in the S1PR1 gene, this would
presumably be an indirect effect, possibly a consequence of
reduced Wisp3. This hypothesis is an obvious avenue for
future investigation.May 2021 | Volume 12 | Article 582614
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It is known that there are multiple copies of Sry in the FCG
model (22), and Sry mRNA is expressed at a higher level in FCG
males than in WT males, at least in brain (60). Moreover, the sex
difference in terms of splenic cell number is exaggerated in this
model (unpublished observation). The benefits of an exaggerated
model include a greater ability to detect changes in response to
experimental manipulation, but the dangers are, of course, that
overexpression of Sry could introduce factors not representative
of normal physiology. However, although those caveats may be
relevant for some of the results, at least two major conclusions of
the current study are not related to the FCG model: first is the
intrathymic use of sex steroids, which occurs in both males and
females, including the XX females, which are entirely normal.
The second is the impact of the testosterone surge in males since
this occurs in both FCG and wildtype males.
Immune Significance
While numbers of total CD4+ and CD8+ cells in the spleen do
not directly correlate with differences in peripheral immune
responses, having more CD4+and CD8+ cells in female spleens
allows for a higher level of antigen screening of the blood and
subsequent T cell proliferation and distribution of effector cells to
peripheral non-lymphoid tissues in response to infection (61).
Also, of note in this regard was the greater proportion of
potential effector T cells to Tregs in females, which statistically
could increase the chance of more profound immune responses.
We conclude that the work has uncovered early development
of sex differences in the immune system and previously
unrecognized roles for steroid hormones in the regulation of
cell development and egress in the neonatal thymus and in the
seeding of T cells to the spleen. In addition, sex differences in
CD8+ cell numbers and distribution are likely the result of an
indirect effect of Sry on expression of S1PR1 receptors.DATA AVAILABILITY STATEMENT
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et al. Naive T Cells Proliferate Strongly in Neonatal Mice in Response to Self-
Peptide/self-MHC Complexes. Proc Natl Acad Sci USA (2002) 99:4538–43.
doi: 10.1073/pnas.062621699
31. Priyadharshini B, Welsh RM, Greiner DL, Gerstein RM, Brehm MA.
Maturation-Dependent Licensing of Naive T Cells for Rapid TNF
Production. PloS One (2010) 5:e15038. doi: 10.1371/journal.pone.0015038
32. Pellicciari C, Bottone MG, Schaack V, Barni S, Manfredi AA. Spontaneous
Apoptosis of Thymocytes is Uncoupled With Progression Through the Cell
Cycle. Exp Cell Res (1996) 229:370–7. doi: 10.1006/excr.1996.0382
33. McLeod DG. Antiandrogenic Drugs. Cancer (1993) 71(3 Suppl):1046–9. doi:
10.1002/1097-0142(19930201)71:3+<1046::AID-CNCR2820711424>
3.0.CO;2-M
34. Bhatnagar AS, Häusler A, Schieweck K, Lang M, Bowman R. Highly Selective
Inhibition of Estrogen Biosynthesis by CGS 20267, a New non-Steroidal
Aromatase Inhibitor. J Steroid Biochem Mol Biol (1990) 37:1021–7. doi:
10.1016/0960-0760(90)90460-3
35. Chen Y, Qiao S, Tuckermann J, Okret S, Jondal M. Thymus-derived
Glucocorticoids Mediate Androgen Effects on Thymocyte Homeostasis.
FASEB J (2010) 24:5043–51. doi: 10.1096/fj.10.168724
36. Stocco DM, Zhao AH, Tu LN, Morohaku K, Selvaraj V. A Brief History of the
Search for the Protein(s) Involved in the Acute Regulation of Steroidogenesis.
Mol Cell Endocrinol (2017) 441:7–16. doi: 10.1016/j.mce.2016.07.036
37. Hager-Theodorides AL, Ross SE, Sahni H, Mishina Y, Furmanski AL,
Crompton T. Direct BMP2/4 Signaling Through BMP Receptor IA
Regulates Fetal Thymocyte Progenitor Homeostasis and Differentiation
to CD4+CD8+ Double-Positive Cell. Cell Cycle (2014) 13:324–33. doi:
10.4161/cc.27118
38. Zamora-Pineda J, Kumar A, Suh JH, Zhang M, Saba JD. Dendritic Cell
sphingosine-1-phosphate Lyase Regulates Thymic Egress. J Exp Med (2016)
213:2773–91. doi: 10.1084/jem.20160287
39. Maeda Y, Yagi H, Takemoto K, Utsumi H, Fukunari A, Sugahara K, et al. S1P
Lyase in Thymic Perivascular Spaces Promotes Egress of Mature Thymocytes
Via Up-Regulation of S1P Receptor 1. Int Immunol (2014) 26:245–55. doi:
10.1093/intimm/dxt069
40. Pyne NJ, McNaughton M, Boomkamp S, MacRitchie N, Evangelisti C,
Martelli AM, et al. Role of Sphingosine 1-Phosphate Receptors, Sphingosine
Kinases and Sphingosine in Cancer and Inflammation. Adv Biol Regul (2016)
60:151–9. doi: 10.1016/j.jbior.2015.09.001
41. Takeda A, Hossain MS, Rantakari P, Simmons S, Sasaki N, Salmi M, et al.
Thymocytes in Lyve1-CRE/S1pr1f/f Mice Accumulate in the Thymus Due to
Cell-Intrinsic Loss of Sphingosine-1-Phosphate Receptor Expression. Front
Immunol (2016) 7:489. doi: 10.3389/fimmu.2016.00489
42. Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King
JK, et al. A Role for Sex Chromosome Complement in the Female Bias
in Autoimmune Disease. J Exp Med (2008) 205:1099–108. doi: 10.1084/
jem.20070850
43. Du S, Itoh N, Askarinam S, Hill H, Arnold AP, Voskuhl RR. XY Sex
Chromosome Complement, Compared With XX, in the CNS Confers Greater
Neurodegeneration During Experimental Autoimmune Encephalomyelitis. Proc
Natl Acad Sci USA (2014) 111:2806–11. doi: 10.1073/pnas.1307091111
44. Dragin N, Bismuth J, Cizeron-Clairac G, Biferi MG, Berthault C, Serraf A,
et al. Estrogen-Mediated Downregulation of AIRE Influences Sexual
Dimorphism in Autoimmune Diseases. J Clin Invest (2016) 126:1525–37.
doi: 10.1172/JCI81894
45. Zhu ML, Bakhru P, Conley B, Nelson JS, Free M, Martin A, et al. Sex Bias in
CNS Autoimmune Disease Mediated by Androgen Control of Autoimmune
Regulator. Nat Commun (2016) 7:11350. doi: 10.1038/ncomms11350
46. Vacchio MS, Papadopoulos V, Ashwell JD. Steroid Production in the Thymus:
Implications for Thymocyte Selection. J Exp Med (1994) 179:1835–46. doi:
10.1084/jem.179.6.1835
47. Pazirandeh A, Xue Y, Rafter I, Sjovall J, Jondal M, Okret S. Paracrine
Glucocorticoid Activity Produced by Mouse Thymic Epithelial Cells. FASEB
J (1999) 13:893–901. doi: 10.1096/fasebj.13.8.893
48. Prenek L, Boldizsár F, Kugyelka R, Ugor E, Berta G, Németh P, et al. The
Regulation of the Mitochondrial Apoptotic Pathway by GlucocorticoidMay 2021 | Volume 12 | Article 582614
Ghosh et al. Perinatal Influences on ImmunityReceptor in Collaboration With Bcl-2 Family Proteins in Developing T Cells.
Apoptosis (2017) 22:239–53. doi: 10.1007/s10495-016-1320-8
49. Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T Cell Development and
Function. Annu Rev Immunol (2000) 18:309–45. doi: 10.1146/
annurev.immunol.18.1.309
50. Ventevogel MS, Sempowski GD. Thymic Rejuvenation and Aging. Curr Opin
Immunol (2013) 25:516–22. doi: 10.1016/j.coi.2013.06.002
51. McCarthy MM. Estradiol and the Developing Brain. Physiol Rev (2009) 88:91–
124. doi: 10.1152/physrev.00010.2007
52. Xu X, Ge Q. Maturation and Migration of Murine CD4 Single Positive
Thymocytes and Thymic Emigrants. Comput Struct Biotechnol J (2014) 9:
e201403003. doi: 10.5936/csbj.201403003
53. Bearman RM, Bensch KG, Levine GD. The Normal Human Thymic
Vasculature: An Ultrastructural Study. Anat Rec (1975) 183:485–97. doi:
10.1002/ar.1091830402
54. Moussad EE, Brigstock DR. Connective Tissue Growth Factor: What’s in a
Name? Mol Genet Metab (2000) 71:276–92. doi: 10.1006/mgme.2000.3059
55. Perbal B. The CCN Family of Cell Growth Regulators: A New Family of
Normal and Pathologic Cell Growth and Differentiation Regulators: Lessons
From the First International Workshop on CCN Gene Family. Bull Cancer
(2001) 88:645–9.
56. Tank J, Lindner D, Wang X, Stroux A, Gilke L, Gast M, et al. Single-Target
RNA Interference for the Blockade of Multiple Interacting Proinflammatory
and Profibrotic Pathways in Cardiac Fibroblasts. J Mol Cell Cardiol (2014)
66:141–56. doi: 10.1016/j.yjmcc.2013.11.004
57. Nakamura Y,Weidinger G, Liang JO, Aquilina-Beck A, Tamai K, Moon RT, et al.
The CCN Family Member Wisp3, Mutant in Progressive PseudorheumatoidFrontiers in Endocrinology | www.frontiersin.org 19Dysplasia, Modulates BMP and Wnt Signaling. J Clin Invest (2007) 117:3075–86.
doi: 10.1172/JCI32001
58. Nakamura Y, Cui Y, Fernando C, Kutz WE, Warman ML. Normal Growth
and Development in Mice Over-Expressing the CCN Family Member WISP3.
J Cell Commun Signal (2009) 3:105–13. doi: 10.1007/s12079-009-0040-z
59. Skon CN, Lee J-Y, Anderson KG, Masopust D, Hogquist KA, Jameson SC.
Transcriptional Downregulation of S1pr1 is Required for Establishment of
Resident Memory CD8+ T Cells. Nat Immunol (2013) 14:1285–93. doi:
10.1038/ni.2745
60. Manwani B, Bentivegna K, Benashski SE, Venna VR, Xu Y, Arnold AP, et al.
Sex Differences in Ischemic Stroke Sensitivity are Influenced by Gonadal
Hormones, Not by Sex Chromosome Complement. Cereb Blood Flow Metab
(2015) 35:221–9. doi: 10.1038/jcbfm.2014.186
61. Bronte V, Pittet MJ. The Spleen in Local and Systemic Regulation of
Immunity. Immunity (2013) 39:806–18. doi: 10.1016/j.immuni.2013.10.010
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Ghosh, Chen, Dill-Garlow, Ma, Yonezawa, Itoh, Rivera, Radecki,
Wu, Arnold, Muller and Walker. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal is
cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.May 2021 | Volume 12 | Article 582614
